ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.  

 

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest clinical science presentations in cardiology at the 2020 annual congress digital meeting. The meeting has gone virtual due to the ongoing pandemic. 
News | ESC | July 21, 2020
The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest...
ESC Congress Goes Virtual Amid COVID-19 Concerns. #ESC #ESCcongress
News | ESC | May 06, 2020
May 6, 2020 — The European Society of Cardiology (ESC), one of the world's largest cardiovascular conferences, is...
News | Coronavirus (COVID-19) | March 27, 2020
March 27, 2020 — The European Society of Cardiology (ESC) has created a novel coronavirus resource page with...
The European Society of Cardiology (ESC) is recommending in novel coronavirus (COVID-19) patients not discontinuing angiotensin converting enzyme inhibitors (ACE-i) or angiotensin receptor blockers (ARBs) used to control hypertension. 
News | Coronavirus (COVID-19) | March 16, 2020 | Dave Fornell, Editor
March 16, 2020 — The European Society of Cardiology (ESC) issued a statement March 13 recommending in novel coronavirus...
The European Heart Rhythm Association (EHRA) electrophysiology (EP) annual meeting cancelled due to coronavirus. #COVID19 #coronavirus #2019nCoV
Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor
March 10, 2020 — Novel coronavirus (COVID-19) has claimed another large cardiology meeting, the European Heart Rhythm...
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both European Society of Cardiology (ESC)...
Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival
News | Cath Lab | September 25, 2019
September 25, 2019 — Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting...
Aspirin Should Not Be Recommended for Healthy People Over 70
News | Antiplatelet and Anticoagulation Therapies | September 20, 2019
September 20, 2019 — Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in...
Early ICD Use Prolongs Survival After Coronary Stenting
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention...
Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes
News | Blood Testing | September 18, 2019
September 18, 2019 — Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-...
FDA Grants Fast Track Designation for Farxiga in Heart Failure
News | Heart Failure | September 18, 2019
September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track...
New ESC Guideline Provides Class 1 Recommendation for Coronary CTA
News | CT Angiography (CTA) | September 17, 2019
September 17, 2019 — The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management...
Reducing Secondary Mitral Regurgitation in Heart Failure Does Not Improve Two-year Outcomes
News | Heart Valve Technology | September 11, 2019
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not...
 Tiny Wearable Cameras May Improve Quality of Life in Heart Failure Patients

Image courtesy of Amazon.com

News | Heart Failure | September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but...
PARAGON-HF Misses Endpoint in Preserved Heart Failure
News | Heart Failure | September 11, 2019
September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint...